JKJoachim Klose

Joachim Klose

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joachim Klose has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Lei Mao

    Institute for Human Genetics, Charité – University Medicine Berlin, Berlin, Germany

    4 shared publications
  • Claus Zabel

    Institute for Human Genetics, Charité – University Medicine Berlin, Berlin, Germany

    3 shared publications
  • Grit Nebrich

    Institute for Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany

    3 shared publications
  • Hans Lehrach

    Max-Planck-Institut für molekulare Genetik, Ihnestrasse 73, Berlin, D-14195, Germany

    3 shared publications
  • Christina Nock

    Institut für Humangenetik, Humboldt-Universität zu Berlin, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, Berlin, D-13353, Germany

    2 shared publications
  • Christine Gauss

    Max-Planck Institut für Molekulare Genetik, Berlin, Germany

    2 shared publications

Latest Publications

  • Individualized proteomics

    by Stefanie Forler, Oliver Klein, Joachim Klose


  • Application of two‐dimensional gel‐based mass spectrometry to functionally dissect resistance to targeted cancer therapy

    by Oliver Klein, Nadine Rohwer, Katja Freitag de Molina, Stefan Mergler, Petra Wessendorf, Marion Herrmann, Joachim Klose, Thorsten Cramer

    Purpose: The majority of gastric cancers are diagnosed at advanced stages, characterized by robust therapy resistance. The oncoprotein hypoxia‐inducible factor 1 (HIF‐1) is associated with therapy resistance, partly via activation of the DNA damage response. We have noted a robust ability of gastric cancer cells to functionally compensate the loss of HIF‐1 in vitro. The purpose of this study was to identify molecular pathways that underlie this compensation.Experimental design: We performed 2DE to compare the nuclear proteome of wild‐type and HIF‐1‐deficient gastric cancer cells. Differently expressed protein spots were identified via MS). After bioinformatic evaluation, functional validation of selected identified pathways was performed.Results: 2DE displayed a total of 2523 protein spots, from which 87 were identified as regulated by HIF‐1. Seventy of the identified spots were different proteins and 17 were isoforms. Bioinformatic analyses revealed that a significant amount of the identified proteins were related to cellular survival pathways. Specifically, members of the proteasome pathway were found upregulated upon loss of HIF‐1. Combined inhibition of HIF‐1 and the proteasome inflicted significant DNA damage, supporting the hypothesis that the proteasome is of functional importance to compensate the loss of HIF‐1.Conclusions and clinical relevance: Our data show robust and functional changes of the nuclear proteome upon inactivation of the HIF‐1 oncoprotein in gastric cancer cells. We propose that 2DE‐MS represents a useful tool to functionally dissect resistance mechanisms to targeted therapy and to identify novel targets for antiproliferative combination therapy.


  • Open Access

    Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease

    by Madeleine Diedrich, Tohru Kitada, Grit Nebrich, Andrea Koppelstaetter, Jie Shen, Claus Zabel, Joachim Klose, Lei Mao

    Parkinson's disease (PD) is histologically well defined by its characteristic degeneration of dopaminergic neurons in the substantia nigra pars compacta. Remarkably, divergent PD-related mutations can generate comparable brain region specific pathologies. This indicates that some intrinsic region-specificity respecting differential neuron vulnerability exists, which codetermines the disease progression. To gain insight into the pathomechanism of PD, we investigated protein expression and protein oxidation patterns of three different brain regions in a PD mouse model, the PINK1 knockout mice (PINK1-KO), in comparison to wild type control mice. The dysfunction of PINK1 presumably affects mitochondrial turnover by disturbing mitochondrial autophagic pathways. The three brain regions investigated are the midbrain, which is the location of substantia nigra; striatum, the major efferent region of substantia nigra; and cerebral cortex, which is more distal to PD pathology. In all three regions, mitochondrial proteins responsible for energy metabolism and membrane potential were significantly altered in the PINK1-KO mice, but with very different region specific accents in terms of up/down-regulations. This suggests that disturbed mitophagy presumably induced by PINK1 knockout has heterogeneous impacts on different brain regions. Specifically, the midbrain tissue seems to be most severely hit by defective mitochondrial turnover, whereas cortex and striatum could compensate for mitophagy nonfunction by feedback stimulation of other catabolic programs. In addition, cerebral cortex tissues showed the mildest level of protein oxidation in both PINK1-KO and wild type mice, indicating either a better oxidative protection or less reactive oxygen species (ROS) pressure in this brain region. Ultra-structural histological examination in normal mouse brain revealed higher incidences of mitophagy vacuoles in cerebral cortex than in striatum and substantia nigra. Taken together, the delicate balance between oxidative protection and mitophagy capacity in different brain regions could contribute to brain region-specific pathological patterns in PD.


  • Open Access

    A mouse embryonic stem cell bank for inducible overexpression of human chromosome 21 genes

    by Rossella De Cegli, Antonio Romito, Simona Iacobacci, Lei Mao, Mario Lauria, Anthony O Fedele, Joachim Klose, Christelle Borel, Patrick Descombes, Stylianos E Antonarakis, et al.

    Background: Dosage imbalance is responsible for several genetic diseases, among which Down syndrome is caused by the trisomy of human chromosome 21. Results: To elucidate the extent to which the dosage imbalance of specific human chromosome 21 genes perturb distinct molecular pathways, we developed the first mouse embryonic stem (ES) cell bank of human chromosome 21 genes. The human chromosome 21-mouse ES cell bank includes, in triplicate clones, 32 human chromosome 21 genes, which can be overexpressed in an inducible manner. Each clone was transcriptionally profiled in inducing versus non-inducing conditions. Analysis of the transcriptional response yielded results that were consistent with the perturbed gene's known function. Comparison between mouse ES cells containing the whole human chromosome 21 (trisomic mouse ES cells) and mouse ES cells overexpressing single human chromosome 21 genes allowed us to evaluate the contribution of single genes to the trisomic mouse ES cell transcriptome. In addition, for the clones overexpressing the Runx1 gene, we compared the transcriptome changes with the corresponding protein changes by mass spectroscopy analysis. Conclusions: We determined that only a subset of genes produces a strong transcriptional response when overexpressed in mouse ES cells and that this effect can be predicted taking into account the basal gene expression level and the protein secondary structure. We showed that the human chromosome 21-mouse ES cell bank is an important resource, which may be instrumental towards a better understanding of Down syndrome and other human aneuploidy disorders.


  • From 2‐D electrophoresis to proteomics

    by Joachim Klose

    At first, a short history of the beginning of 2‐DE is provided. Based on the present state of the art at the time I developed a 2‐DE technique in 1975 that was able to resolve complex protein extracts from mouse tissues in hundreds of protein spots. My intention was to study proteins from a global point of view. Questions of interest were, how do proteins change during embryonic development, and what is the effect of induced mutations on the protein level. At that time protein chemistry was a matter of analyzing single proteins in detail. Therefore, my approach was frequently criticized as inappropriate because it would be impossible to identify and characterize the hundreds of proteins resolved. But soon it was realized that studying total proteins gives opportunities to answer many interesting questions. This led to a research field nowadays called “proteomics”. Already in the beginning of the 1980s the idea to analyze the total human proteins had come up. By entering the post‐genome era it became obvious that a human proteome project is needed in order to explain the human genome in terms of its functions. The problems in realizing such a project are considered.


  • Proteome analysis of ventral midbrain in MPTP‐treated normal and L1cam transgenic mice

    by Madeleine Diedrich, Lei Mao, Christian Bernreuther, Claus Zabel, Grit Nebrich, Ralf Kleene, Joachim Klose

    Treatment of mice by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridene hydrochloride (MPTP) is a well established animal model for Parkinson's disease (PD), while overexpression of L1 cell adhesion molecule (L1cam) has been proposed to attenuate the degeneration of dopaminergic neurons induced by MPTP. To gain insight into the role of L1cam in the pathomechanism of PD, we investigated protein expression patterns after MPTP‐treatment in both C57BL/6 (wild‐type) and transgenic mice overexpressing L1cam in astrocytes. Our results showed that during the acute phase, proteins in functional complexes responsible for mitochondrial, glycolysis, and cytoskeletal function were down‐regulated in MPTP‐treated wild‐type mice. After a recovery phase, proteins that were down‐regulated in the acute phase reverted to normal levels. In L1cam transgenic mice, a much higher number of proteins was altered during the acute phase and this number even increased after the recovery phase. Many proteins involved in oxidative phosphorylation were still down‐regulated and glycolysis related protein were still up‐regulated. This pattern indicates a lasting severely impaired energy production in L1cam mice after MPTP treatment.


  • Transcriptome and proteome analysis of early embryonic mouse brain development

    by Daniela Hartl, Martin Irmler, Irmgard Römer, Michael T. Mader, Lei Mao, Claus Zabel, Martin Hrabé de Angelis, Johannes Beckers, Joachim Klose

    Mouse embryonic brain development involves sequential differentiation of multipotent progenitors into neurons and glia cells. Using microarrays and large 2‐DE, we investigated the mouse brain transcriptome and proteome of embryonic days 9.5, 11.5, and 13.5. During this developmental period, neural progenitor cells shift from proliferation to neuronal differentiation. As expected, we detected numerous expression changes between all time points investigated, but interestingly, the rate of alteration remained in a similar range within 2 days of development. Furthermore, up‐ and down‐regulation of gene products was balanced at each time point which was also seen at embryonic days 16–18. We hypothesize that during embryonic development, the rate of gene expression alteration is rather constant due to limited cellular resources such as energy, space, and free water. A similar complexity in terms of expressed genes and proteins suggests that changes in relative concentrations rather than an increase in the number of gene products dominate cellular differentiation. In general, expression of metabolism and cell cycle related gene products was down‐regulated when precursor cells switched from proliferation to neuronal differentiation (days 9.5–11.5), whereas neuron specific gene products were up‐regulated. A detailed functional analysis revealed their implication in differentiation related processes such as rearrangement of the actin cytoskeleton as well as Notch‐ and Wnt‐signaling pathways.


    • 1 February 2008
      • Vol. 7  (2) , 457

    HUPO Brain Proteome Project: toward a code of conduct.

    by Michael Hamacher, Katrin Marcus, Christian Stephan, Joachim Klose, Young Mok Park, Helmut E Meyer


  • Evaluation of 2‐DE protein patterns from pre‐ and postnatal stages of the mouse brain

    by Ingo Seefeldt, Grit Nebrich, Irmgard Römer, Lei Mao, Joachim Klose

    Brains of the mouse from three developmental stages, embryo day 16 (Ed16), postnatal stage one week (1W) and eight weeks (8W), were distributed to different laboratories for a collaborative proteome analysis (The Human Brain Proteome Project). As one of the laboratories involved in this project, we separated total protein extracts of the brains by large gel 2‐DE. From the 2‐DE protein patterns a section was evaluated for each of the three stages according to resolution, reproducibility and quantitative changes using an image analysis software. The evaluated pattern section was selected to allow comparisons of 2‐DE patterns between different laboratories on the basis of optimum separation. Changes in protein expression were analysed within two phases of development: Stage Ed16 versus stage 1W and stage 1W versus stage 8W. Out of the 200 protein spots evaluated 5–6% showed quantitative changes in the range of ≥30% between two stages. The relationship in the frequency of up‐ and down‐regulated protein spots differed between the two investigated phases. Most of the protein spots which showed altered expression between two stages were identified by MS. High quality in protein separation and evaluation is demonstrated.


  • Estimation of the mtDNA mutation rate in aging mice by proteome analysis and mathematical modeling

    by Lei Mao, Claus Zabel, Maik A. Wacker, Grit Nebrich, Dijana Sagi, Petra Schrade, Sebastian Bachmann, Axel Kowald, Joachim Klose